OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: BrainScope Company, Inc

1 Projects | 1 Researchers | $491,086 Invested

2022

BrainScope Company, Inc

Leslie Prichep, PhD

Use of an intrinsic brain activity biomarker for the earliest prediction of cognitive decline

  • Funding Amount: $491,086
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Digital tools
  • Status: Active